Attendees are responsible for booking their own rooms at the New York Hilton Midtown. Room reservations made by Thursday, May 23, 2019 will be eligible for the group rate of $399.00 plus applicable taxes and fees for single or double occupancy. The negotiated group rate is based on availability and applies to reservations for Sunday, June 9, 2019 through Wednesday, June 12, 2019.
An ageing population and the associated increased prevalence of chronic illness is already placing enormous pressure on the NHS and healthcare delivery. Exacerbated by workforce challenges, the long tail of the covid-19 pandemic, and a worsening fiscal environment, the challenge for the NHS and the future of healthcare delivery is clear for all to see.
Through a series of panel discussions with senior thought leaders from public policy, industry, and the wider healthcare system we will explore how investment and uptake of innovation in life sciences and healthcare can both: help the NHS to tackle the challenges it faces today and support it for the future; and ensure the UK grows and maintains global leadership in life sciences.
Health and care are facing unprecedented operational and financial constraints and the NHS is struggling in the face of increasing demand, workforce challenges, and a desperate fiscal environment. Matthew Swindells, Patricia Hewitt and Camilla Cavendish will discuss the key challenges facing the NHS today and, the lessons learned from past approaches to the delivery of healthcare, and what should be at the forefront of policy makers minds as they formulate solutions for sustainable health and care delivery in the future.
Innovation in the NHS: What is needed to exploit life sciences to transform care today, into the 2030s, and beyond?
A perennial problem facing innovators is how to successfully engage the NHS in both supporting the research and development of novel technologies, but also in seeing their procurement and uptake by the health system. This discussion features innovators from across the life science and digital health on their experiences in developing and launching products in the NHS and from NHS trusts on uptake of innovative technologies.
Healthcare delivered at home, the community or pharmacies has long been identified as central to the changing care model. This discussion considers how policy can be deployed to make good on the vision of a tech-enabled, pluralist care delivery model. What ‘buying signals’ might industry need to appropriately tailor solutions to the unique needs of the NHS? What barriers currently exist to implementation? And what unintended consequences do policymakers need to be aware of before hitting go?
Global Counsel works with companies and investors across a wide range of sectors to anticipate the ways in which politics, regulation and public policymaking create both risk and opportunity – and to develop and implement strategies to meet these challenges.
From high-level in-conversations and policy webinars, to large scale conferences, our events draw from a network of government, industry, academia and civil society to foster debate and discussion.
